COOPER GLENN L MD 4/A
4/A · REPLIGEN CORP · Filed Jun 19, 2019
Insider Transaction Report
Form 4/AAmended
REPLIGEN CORPRGEN
COOPER GLENN L MD
Director
Transactions
- Exercise/Conversion
Common Stock
2019-05-23$5.00/sh+24,000$120,000→ 64,709 total - Sale
Common Stock
2019-05-23$66.91/sh−4,734$316,752→ 59,975 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-05-23−24,000→ 0 totalExercise: $5.00Exp: 2019-08-24→ Common Stock (24,000 underlying) - Sale
Common Stock
2019-05-23$67.53/sh−266$17,963→ 59,709 total
Footnotes (4)
- [F1]Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock.
- [F2]$66.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.42 to $67.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]$67.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.52 to $67.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]This option is currently exercisable.